We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Hypoxia Factors Contribute to Maintenance of Regulatory T-cell Function

By LabMedica International staff writers
Posted on 29 Jun 2015
Print article
Image: A colorized scanning electron micrograph (SEM) of a T lymphocyte. Regulatory T-cells (Treg cells) are critically important for preventing the body’s immune response from going overboard and causing autoimmune disease (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).
Image: A colorized scanning electron micrograph (SEM) of a T lymphocyte. Regulatory T-cells (Treg cells) are critically important for preventing the body’s immune response from going overboard and causing autoimmune disease (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).
A team of cell biologists has identified a molecular pathway that maintains the stability and function of regulatory T-cells (Treg cells), which are components of the immune system that suppress immune responses of other cells and act as an important “self-check” built into the immune system to prevent excessive reactions.

Foxp3+ regulatory Treg cells play a critical role in immune homeostasis; however, the mechanisms to maintain their function have not been clarified. In this regard, investigators at the La Jolla Institute for Allergy and Immunology (CA, USA) worked with a genetically engineered mouse model to determine how Treg function was maintained.

The mice were engineered to lack the gene that encodes the enzyme von Hippel-Lindau (VHL). Among the activities carried out by VHL is regulating hypoxia-inducible factor 1alpha (HIF-1alpha), an oxygen sensor that controls the expression of various genes for glucose metabolism under conditions of low oxygen levels.

The investigators reported in the June 16, 2015 online edition of the journal Immunity that the amount of HIF-1alpha within Treg cells lacking VHL increased sharply. In addition, the Treg cells became highly activated and produced large amounts of inflammatory cytokines, such as interferon-gamma (INF-gamma). HIF-1alpha knockdown or knockout could reverse the increased IFN-gamma production by VHL-deficient Treg cells and restore their suppressive function in vivo.

“Due to the inhibitory function of Treg cells, people have been trying to use these cells for therapy in human autoimmune diseases or transplantation,” said senior author Dr. Yun Cai Liu, professor of cell biology at the La Jolla Institute for Allergy and Immunology. “Our results suggest that these cells may not be stable, and, under certain conditions, may be even converted into inflammatory cells. Our studies imply that the change of oxygen levels in different tissues can be sensed by Treg cells and that this process is critically important for maintaining the correct balance between activation and suppression of the immune system.”

Related Links:

La Jolla Institute for Allergy and Immunology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.